BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 11359018)

  • 1. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of plasma levels of mature adrenomedullin and natriuretic peptide as markers of cardiac function in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Tamura M; Anai H; Kabashima N; Suda T; Iwamoto M; Ota T; Watanabe Y; Kanegae K; Nakashima Y
    Nephron; 2002 Dec; 92(4):832-9. PubMed ID: 12399629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease.
    Nishikimi T; Futoo Y; Tamano K; Takahashi M; Suzuki T; Minami J; Honda T; Uetake S; Asakawa H; Kobayashi N; Horinaka S; Ishimitsu T; Matsuoka H
    Am J Kidney Dis; 2001 Jun; 37(6):1201-8. PubMed ID: 11382689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot.
    Hayabuchi Y; Matsuoka S; Kuroda Y
    Pediatr Cardiol; 1999; 20(5):343-50. PubMed ID: 10441688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure.
    Haug C; Metzele A; Kochs M; Hombach V; Grünert A
    Clin Cardiol; 1993 Jul; 16(7):553-7. PubMed ID: 8348764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of natriuretic peptides in patients on hemodialysis.
    Takahashi M; Nagake Y; Ichikawa H; Kawabata K; Nakazono H; Hirata K; Ogura T; Makino H
    Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):19-30. PubMed ID: 8733825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
    Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T
    Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.
    Haug C; Metzele A; Steffgen J; Kochs M; Hombach V; Grünert A
    Clin Investig; 1994 Jun; 72(6):430-4. PubMed ID: 7950153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction.
    Friedl W; Mair J; Thomas S; Pichler M; Puschendorf B
    Heart; 1996 Aug; 76(2):129-36. PubMed ID: 8795474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cGMP level as a marker of the hydration state in renal replacement therapy.
    Lauster F; Heim JM; Drummer C; Fülle HJ; Gerzer R; Schiffl H
    Kidney Int Suppl; 1993 Jun; 41():S57-9. PubMed ID: 8391608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
    Franz M; Woloszczuk W; Hörl WH
    Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mature form of adrenomedullin correlates with brain natriuretic peptide in plasma of chronic hemodialysis patients.
    Suda T; Osajima A; Iwamoto M; Anai H; Tamura M; Kabashima N; Ota T; Watanabe Y; Kanegae K; Okazaki M; Nakashima Y
    Clin Nephrol; 2002 Jun; 57(6):444-51. PubMed ID: 12078948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
    Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
    Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
    Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of left ventricular diastolic function on natriuretic peptide levels after cardioversion of atrial fibrillation.
    Bakowski D; Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2009 Apr; 67(4):361-7. PubMed ID: 19492248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction.
    Tulevski II; Groenink M; van Der Wall EE; van Veldhuisen DJ; Boomsma F; Stoker J; Hirsch A; Lemkes JS; Mulder BJ
    Heart; 2001 Jul; 86(1):27-30. PubMed ID: 11410557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis.
    Nitta K; Kawashima A; Yumura W; Naruse M; Oba T; Kabaya T; Nihei H
    Am J Nephrol; 1998; 18(5):411-5. PubMed ID: 9730565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraindividual comparison of ANP, cGMP and plasma catecholamines between HD and CAPD.
    Plum J; Ziyaie M; Kemmer FW; Passlick-Deetjen J; Grabensee B
    Adv Perit Dial; 1990; 6():211-9. PubMed ID: 1982811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.